Herpes Singapore Clinic

Herpes Singapore Clinic: Genital herpes, cold sores, oral herpes, herpes simplex - symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Singapore - Private and confidential service. Definitions, references, and latest news.

Description

Herpes simplex is caused by the Herpes simplex virus 1 & 2 (HSV-1 & HSV-2), diagnosed with the herpes type-specific blood test and is usually treated with Aciclovir/Acyclovir

The signs of herpes appear about 2-10 days after sexual contact with an infected person.

These include:

• itching/burning-feeling in the genital area
• water blisters (vesicles) or open sores
• discharge of fluid from the vagina.

References

• Herpes - Wikipedia, the free encyclopedia
• Herpes: Definition from Answers.com
• Herpes - definition of Herpes in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
• WHO | Herpes virus type 2
• Genital Herpes - STD information from CDC
• Herpesviridae - Human herpes virus infections

Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: An autopsy series
Thu, 29 Jul 2010 05:31:40 +0100 | Burns : Journal of the International Society for Burn Injuries
This study is a retrospective review of all autopsy reports from patients with severe thermal burns treated at the US Army Institute of Research (USAISR) burn unit over 12 years. The review focused on those patients with death attributed to a bacterial or viral cause by autopsy report. Of 3751 admissions, 228 patients died with 97 undergoing autopsy. Death was attributed to bacteria for 27 patients and to virus for 5 patients. Bacterial pathogens associated with mortality included Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus. This association with mortality was independent of % total body surface area burn, % full-thickness burn, inhalation injury, and day of death post-burn. Bloodstream infection was the most common cause of bacteria related de...

DIATHERIX Laboratories Launches STD And HSV Test Panel
Wed, 28 Jul 2010 09:00:00 +0100 | Health News from Medical News Today
DIATHERIX Laboratories, adds a Sexually Transmitted Disease (STD) panel and Herpes Simplex Virus (HSV) panel to its line up of highly sensitive, rapid response diagnostic panels. The HSV panel identifies herpes simplex viruses 1 and 2 and the STD panel identifies 10 sexually transmitted diseases simultaneously, many of which cannot be accurately identified by current testing methods. These STD organisms, if not appropriately treated, can cause diseases such as syphilis, gonorrhoeae, chlamydia, bacterial vaginosis, etc. and may lead to blindness, infertility or complications during pregnancy... (Source: Health News from Medical News Today)

Good early results for herpes vaccine
Tue, 27 Jul 2010 18:07:03 +0100 | bizjournals.com Health Care:Health Insurance headlines
Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine. A vaccine, if approved, would be a blockbuster pharmaceutical product — 60 million Americans are infected with herpes simplex virus-2, more commonly known as genital herpes. (Source: bizjournals.com Health Care:Health Insurance headlines)

Good early results for herpes vaccine
Tue, 27 Jul 2010 18:07:03 +0100 | bizjournals.com Health Care:Biotechnology headlines
Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine. A vaccine, if approved, would be a blockbuster pharmaceutical product — 60 million Americans are infected with herpes simplex virus-2, more commonly known as genital herpes. (Source: bizjournals.com Health Care:Biotechnology headlines)

Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial
Tue, 27 Jul 2010 12:07:14 +0100 | Drugs.com - Clinical Trials
Novel, Multi-Valent, HSV-2 Therapeutic Vaccine Generates CD4+ and CD8+ Immune Responses SALT LAKE CITY--(BUSINESS WIRE)--Jul 27, 2010 - Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine... (Source: Drugs.com - Clinical Trials)

Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and Demonstrate Significant Therapeutic Benefit in Animal Models
Mon, 26 Jul 2010 19:07:05 +0100 | Drugs.com - Clinical Trials
SAN DIEGO, July 26, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that its prophylactic Vaxfectin®-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against... (Source: Drugs.com - Clinical Trials)

Herpes Zoster Vaccine is Tolerated Well But Not Disseminated Widely
Mon, 26 Jul 2010 10:36:31 +0100 | Medscape Today Headlines
Although herpes zoster vaccine is effective and well-tolerated, it is not routinely administered. Is the high cost a barrier? Journal Watch (Source: Medscape Today Headlines)

Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and Demonstrate Significant Therapeutic Benefit in Animal Models
Mon, 26 Jul 2010 10:30:00 +0100 | Medical News (via PRIMEZONE)
SAN DIEGO, July 26, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that its prophylactic Vaxfectin(r)-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against lethal challenge, provided sterilizing immunity and inhibited viral counts at both the primary and latent infection sites. The Vaxfectin(r) adjuvant substantially improved vaccine effectiveness. A related vaccine significantly reduced the recurrence of HSV-2 lesions in a therapeutic model using guinea pigs with latent infection. HSV-2 is a sexually transmitted virus which is the leading cause of genital herpes. Approximately one out of every six individuals in the United States and an estimated one out of every four worldwide is infected by HSV-2 before age 50...

A collaboration solves the herpes virus protein structure providing new drug therapy directions
Mon, 26 Jul 2010 04:00:00 +0100 | EurekAlert! - Medicine and Health
(University of Pennsylvania) The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now researchers reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells. The new map details an essential piece of the herpes virus "cell-entry machinery," providing scientists with a new target for antiviral drugs. (Source: EurekAlert! - Medicine and Health)